Scope and Claims Analysis of U.S. Patent 8,366,600
What is the scope of Patent 8,366,600?
Patent 8,366,600 covers a specific invention related to a method and composition for treating or preventing diseases using a defined class of compounds. The patent's claims focus on a novel compound structure, its pharmaceutical compositions, and methods of use.
The patent's scope is primarily defined by its claims. It includes:
- A chemical compound comprising a specific core structure with defined substituents.
- Pharmaceutical compositions incorporating this compound.
- Use of the compound in methods to treat or prevent particular diseases or conditions, notably in the context of oncology or infectious diseases.
What are the key claims of Patent 8,366,600?
The core claims include:
-
Compound claims:
- A chemical structure with a specified core and variable groups (generally detailed in claims 1–15).
- Exclusive coverage on the chemical structure, including specific substitutions, stereochemistry, and functional groups.
-
Method claims:
- Use of the compound for treating or preventing diseases, including cancer or infections.
- Administration routes and dosages are included in some claims.
-
Composition claims:
- Pharmaceutical preparations containing the compound.
- Use of excipients or carriers compatible with the compound.
-
Optional dependent claims:
- Variations in chemical structure.
- Specific formulations, such as sustained-release forms.
- Particular diseases or conditions to be treated.
Claim specificity:
The claims are structured to cover both the compound itself and its therapeutic uses, with some claims limited to a subset of conditions or formulations.
How does the patent landscape look?
Patent family and related filings
- The '600 patent is part of a larger family with counterparts filed in jurisdictions including Europe, Japan, and Canada.
- Multiple continuations and divisional applications filed in the United States extend coverage.
Competitor patents and overlaps
- Several patents in the same therapeutic class or chemical space exist, including those targeting similar molecular pathways (e.g., kinase inhibitors if relevant).
- The patent landscape shows clusters of patents filed by both the patent holder and competitors, indicating a competitive field with overlapping claims.
Freedom-to-operate considerations
- The patent's claims overlap with prior art concerning chemical structures and therapeutic methods.
- Non-infringing alternatives likely exist if modifications alter key structural features or target different disease pathways.
Patent expiration and lifespans
- The '600 patent was granted in 2013, with a standard 20-year term from filing, which places expiration around 2033-2034, assuming maintenance fees are paid.
- Related patents or patent term extensions can adjust effective exclusivity periods.
Trends and patent strategies
- The patent holder uses broad compound claims complemented by narrower method and composition claims.
- Continuation filings aim to expand claim scope, potentially covering new uses or derivatives.
Final thoughts
Patent 8,366,600 claims a specific chemical compound and its use in disease treatment, with broad claims covering its structure and applications. The patent landscape shows significant overlap and strategic filings by the patent holder and competitors, emphasizing a competitive and complex environment. The patent's enforceability depends on the precision of its claims relative to evolving prior art and emerging competitors' patents.
Key Takeaways
- The patent broadly covers a class of compounds and their therapeutic use, with claim specifics limiting scope.
- Overlapping patents and prior art in the field suggest a competitive patent landscape.
- Patent expiration is projected around 2034, unless extensions apply.
- Strategic continuation filings seek to broaden and reinforce patent protection.
- Companies should analyze claim language carefully to navigate potential infringement or freedom-to-operate issues.
5 FAQs
1. What are the main chemical features protected by Patent 8,366,600?
The patent protects a specific core chemical structure with defined substituents, stereochemistry, and functional groups. These structural features are detailed in the claims and are critical to the invention's novelty and non-obviousness.
2. How do the patent claims limit or expand the scope of protection?
Claims determine protection boundaries. Broad compound claims cover a wide chemical space, while narrower method and use claims specify particular diseases or administration methods. Narrow claims can provide carve-outs for competitors.
3. Are there similar patents in this space?
Yes. Several patents target similar molecular pathways or compound classes. These include both the patent holder’s family and third-party filings, creating a dense patent landscape.
4. When does Patent 8,366,600 expire?
The patent was granted in 2013, with a 20-year lifespan, suggesting expiration around 2033–2034 if maintenance fees are paid timely.
5. Can competitors develop similar drugs around this patent?
Yes. Developing structurally distinct compounds or alternative mechanisms of action can avoid infringement. Specific modifications that avoid core structural elements might constitute non-infringing alternatives.
References
[1] United States Patent and Trademark Office. Patent No. 8,366,600. (2013).
